Feb 8, 2021
Despite some notable improvements to the healthcare system over the last few years, American families and workers still struggle with annual cost increases that, on average, outpace wage growth and annual medical inflation rates. The COVID pandemic and the ongoing...
Jan 22, 2021
In the summer of 2019, the Institute for Clinical and Economic Review (ICER) hosted a public meeting to discuss its value assessments of new treatments for Duchenne muscular dystrophy. For patient advocates and others who follow ICER, the events of that day have...
Jan 8, 2021
There are many reasons for patients and advocates to be concerned about organizations – including the Institute for Clinical and Economic Review (ICER) – that use the Quality Adjusted Life Year (QALY), and their growing influence over insurance coverage for new drugs...
Dec 21, 2020
Many patients, advocates, and caregivers have heard troubling stories about the Institute for Clinical and Economic Review (ICER). They have heard about patients who were denied access to vital treatments because ICER determined the drugs were not cost-effective. They...
Dec 9, 2020
President-elect Biden has a unique opportunity to refocus our health care system on patients in ways we have never seen before. The COVID-19 pandemic presents our greatest challenge and perhaps our greatest opportunity to solve long-standing and emergent health...
Oct 1, 2020
As we enter the final stretch of the 2020 election season, many of us may be reviewing the candidates’ stances on issues of not only personal, but also national, importance as we consider the choices before us. High on this list for many Americans is access to...
